Estring is a Vaginal Ring in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Estradiol.
| Product ID | 0013-2150_12580cdd-51cd-4833-835b-060faf1251bc |
| NDC | 0013-2150 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Estring |
| Generic Name | Estradiol |
| Dosage Form | Ring |
| Route of Administration | VAGINAL |
| Marketing Start Date | 1996-04-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020472 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | ESTRADIOL |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Estradiol Congeners [CS],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1996-04-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020472 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-04-26 |
| Ingredient | Strength |
|---|---|
| ESTRADIOL | 2 mg/1 |
| SPL SET ID: | aa530dfd-3a48-46b9-9678-a7bc48316e41 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0013-2150 | Estring | estradiol |
| 63539-021 | Estring | Estring |
| 0023-5885 | Alora | Estradiol |
| 0023-5886 | Alora | Estradiol |
| 0023-5887 | Alora | Estradiol |
| 0023-5888 | Alora | Estradiol |
| 0037-4801 | ELESTRIN | ESTRADIOL |
| 0037-4802 | ELESTRIN | ESTRADIOL |
| 0078-0343 | Vivelle-Dot | estradiol |
| 0078-0344 | Vivelle-Dot | estradiol |
| 0078-0345 | Vivelle-Dot | estradiol |
| 0078-0346 | Vivelle-Dot | estradiol |
| 0078-0365 | Vivelle-Dot | estradiol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ESTRING 74496606 2086164 Live/Registered |
PFIZER HEALTH AB 1994-03-03 |
![]() ESTRING 74198624 not registered Dead/Abandoned |
Kabi Pharmacia AB 1991-08-27 |